Steven C Gilman has an estimated net worth of $14.4 Million. This is based on reported shares across multiple companies, which include Vericel Corp, CONTRAFECT Corp, Akebia Therapeutics, Inc., SCYNEXIS INC, CUBIST PHARMACEUTICALS INC, MOMENTA PHARMACEUTICALS INC, and KERYX BIOPHARMACEUTICALS INC.

2013 was Steven C Gilman's most active year for acquiring shares with 17 total transactions. Steven C Gilman's most active month to acquire stocks was the month of May. 2014 was Steven C Gilman's most active year for disposing of shares, totalling 26 transactions. Steven C Gilman's most active month to dispose stocks was the month of April. 2014 saw Steven C Gilman paying a total of $5,380,181.66 for 205,529 shares, this is the most they've acquired in one year. In 2015 Steven C Gilman cashed out on 309,954 shares for a total of $3,114,162.00, their largest year based on trade value.